Zoetis is building on a long-term relationship with iosBio, a pioneer in thermostable technologies that preserve the efficacy of medicines and vaccines against high and low temperature extremes.

Zoetis and iosBio entered a three-year collaboration which will explore the potential of the company’s technologies in biopharmaceuticals and vaccines for animals.

Vaccines and other large biomolecules that could be sterilized, transported and stored at room temperature without significant degradation have the potential to transform animal healthcare – especially in developing countries where access to refrigeration in rural areas is a challenge.